Agents that directly lower ACTH secretion by a pituitary adenoma represent an attractive option for the treatment of Cushing's disease, as these drugs directly target the pathogenesis of disease.
As noted, a thorough pretreatment assessment of pituitary function is essential, because most patients develop one or more pituitary hormone deficiencies that can be replaced with appropriate ...